News | April 23, 2026
Croda unveils next-gen Matrixyl Neolide to redefine long-lasting skincare performance
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
The innovation is particularly suited for bone and cartilage repair
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
